Infection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody-Positive Blood Donations
Publication: Annals of Internal Medicine
Volume 113, Number 10
Abstract
Objective: To assess the incidence of human immunodeficiency virus type 1 (HIV-1) transmission by antibody (anti-HIV-1)-positive blood components, and to determine the immunologic and clinical course in HIV-1-infected recipients.
Design and Subjects: We retrospectively tested approximately 200 000 donor blood component specimens stored in late 1984 and 1985 for anti-HIV-1, and we contacted recipients of positive specimens to determine their serologic status. They were compared with both recipients of HIV-1-negative transfusions and healthy (untransfused) controls. Subjects were seen at 3- to 6-month intervals for up to 4 years for clinical and immunologic evaluations.
Measurements and Main Results: Of 133 recipients, 9 had other possible exposures. Excluding these cases, 111 of 124 (89.5%) were anti-HIV-1-positive (95% CI, 84.1% to 94.5%). The recipient's sex, age, underlying condition, and type of component did not influence infection rates. The cumulative risk for developing the acquired immunodeficiency syndrome (AIDS) within 38 months after transfusion was 13% (CI, 7.5% to 21.6%). At 36 ± 3 months after the index transfusion, seropositive recipients had lower counts of CD2+CDw26+, CD4+, CD4+CD29+, and CD4+CD45RA+ subsets and more CD8+I2+ lymphocytes than did recipients of anti-HIV-1-negative transfusions. The CD4+ and CD2+CDw26+ subsets changed the most rapidly. The absolute CD8+ count remained normal.
Conclusions: Transfusion of anti-HIV-1-positive blood infected 90% of recipients. The rate of progression to AIDS within the first 38 months after infection was similar to that reported for homosexual men and hemophiliacs. Although most lymphocyte subset counts changed over time, CD8+ counts were constant.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
. Possible transfusion-associated acquired immune deficiency syndrome (AIDS)—California. MMWR. 1982;31:652-4.
2.
Ammann A, Wara D, and Dritz S. Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet. 1983;1:956-8.
3.
. Human immunodeficiency virus infection in transfusion recipients and their family members. MMWR. 1987;36:137-40.
4.
Ward J, Deppe D, and Samson S. Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immunodeficiency syndrome. Ann Intern Med. 1987;106: 61-2.
5.
Ward J, Bush T, and Perkins H. The natural history of transfusion-associated infection with human immunodeficiency virus: factors influencing the rate of progression to disease. N Engl J Med. 1989;321:947-52.
6.
Ng A, Conway M, Blanda E, Killigrew R, and Eastman C. Tracing HIV-infected blood recipients: large-scale recipient screening vs. look-back testing. JAMA. 1987;258:201-2.
7.
Kleinman S, Niland J, and Azen S. Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening: the Transfusion Safety Study/NHLBI Donor Repository. Transfusion. 1989;29:572-80.
8.
. Update on acquired immune deficiency syndrome (AIDS)—United States. MMWR. 1982;31:507-14.
9.
Revision of the case definition of acquired immunodeficiency syndrome for national reporting—United States. Ann Intern Med. 1985; 103:402-3.
10.
. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 1987; 36:3S-15S.
11.
Edwards V and Mosley J. Reproducibility in quality control of protein (Western) immunoblot assay for antibodies to human immunodeficiency virus. Am J Clin Pathol. 1989;91:75-8.
12.
Fletcher M, Baron G, Ashman M, Fischl M, and Klimas N. Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol. 1987;5:69-81.
13.
Parker J, Adelsberg B, and Azen S. Leukocyte immunophenotyping of recipients of blood products. A multisite flow cytometry study: organization, standardization and quality control. Clin Immunol Immunopathol. 1990;55:187-220.
14.
Howard F, Ledbetter J, Wong J, Biber C, Stitson E, and Hertzenberg L. A human T lymphocyte differentiation marker defined by monoclonal antibodies that block Å-rosette formation. J Immunol. 1981;126:2117-22.
15.
Fox D, Hussey R, and Fitzgerald K. Tal, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol. 1984;133:1250-6.
16.
Tsutomu T, Di Maggio M, Levine H, Schlossman S, and Morimoto C. CD11 molecule defines two types of suppressor cells within the T8+ population. Cell Immunol. 1988;111:398-409.
17.
Kung P, Goldstein G, Reinherz E, and Schlossman S. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979;206:347-9.
18.
Morimoto C, Letvin N, and Boyd A. The isolation and characterization of the human helper inducer T cell subset. J Immunol. 1985;134:3762-9.
19.
Morimoto C, Letvin N, Distaso J, Aldrich W, and Schlossman S. The isolation and characterization of the human suppressor inducer T cell subset. J Immunol. 1985;134:1508-15.
20.
Reinherz E, Kung P, Goldstein G, and Schlossman S. A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol. 1980;124:1301-7.
21.
Horwitz D, Linker-Israeli M, Gray J, and Lemaine C. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus. J Rheumatol 1987;13(Suppl):49-52.
22.
Griffin J, Hercend T, Beveridge R, and Schlossman S. Characterization of an antigen expressed by human natural killer cells. J Immunol. 1983;130:2947-51.
23.
Abo T and Balch C. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981;127:1024-9.
24.
Stashenko P, Nadler L, Hardy R, and Schlossman S. Characterization of a human B lymphocyte specific antigen. J Immunol. 1980;125: 1678-85.
25.
Abo T and Balch C. Characterization of HNK-1+ (Leu7) human lymphocytes. IL Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells. J Immunol. 1982;129:1758-61.
26.
Lawless J. Statistical Models and Methods for Lifetime Data. New York: Wiley; 1982.
27.
Hollander M and Wolfe D. Nonparametric Statistical Methods. New York: Wiley; 1973:114-9.
28.
Archer G, Bolten W, Cook L, Kendrick K, and Learment J. HIV infection in patients following blood transfusion [Abstract]. Program and Abstracts, Book 2, IV International Conference on AIDS. Stockholm: Swedish Ministry of Health and Social Affairs, World Health Organization; 1988:354.
29.
Berglund O, Beckman S, and Grillner L. HIV transmission by blood transfusions in Stockholm 1979-1985: nearly uniform transmission from infected donors. AIDS. 1988;2:51-4.
30.
Niland J. Association of donor characteristics with transmission of HIV infection to recipients [Abstract]. Abstracts Volume, III International Conference on AIDS. Washington, DC: U.S. Department of Health and Human Services, World Health Organization; 1987:24.
31.
. Natural history of primary infection with LAV in multitransfused patients. Blood. 1986; 68:89-94.
32.
Donegan E, Lenes B, Tomasulo P, and Mosley J. Transmission of HIV-1 by component type and duration of shelf storage before transfusion. Transfusion. 1990:30:839-40.
33.
Anderson K, Gorgone B, and Marlick R. Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons. Ann Intern Med. 1986;105:519-27.
34.
Peterman T, Jaffe H, and Feorino P. Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA. 1985;254:2913-7.
35.
Giesecke J, Scalia-Tomba G, Berglund O, Berntorp E, Schulman S, and Stigendal L. Incidence of symptoms and AIDS in 146 Swedish hemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. Br Med J. 1988;297:99-102.
36.
Eyster M, Gail M, and Ballard J. National history of human immunodeficiency virus infections in hemophiliacs; effect of T-cell subsets, platelet counts, and age. Ann Intern Med. 1987;107:1-6.
37.
Mosley J. Effect of age on the expression of human immunodeficiency virus infection among hemophiliacs [Abstract]. Blood. 1987; 70:125 A.
38.
Goedert J, Kessler C, and Aledort L. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med. 1989; 321:1141-8.
39.
Jason J, Hilgartner M, and Holman R. Immune status of blood transfusion recipients. JAMA. 1985;253:1140-5.
40.
Klimas N, Morgan R, Salvato F, and Fletcher M. Natural killer cells and T lymphocytes in chronic fatigue syndrome. Rev Infect Dis. 1989; [In press].
41.
Schriemer P, Longnecker D, and Mintz P. Possible immunosuppressive effects of perioperative blood transfusion in cancer patients. Anesthesiology. 1988;68:422-8.
42.
Lennard T, Shenton B, and Borzotta A. The influence of surgical operations on components of the human immune system. Br J Surg. 1985;72:771-6.
43.
Lynch F and Kirov S. Changes in blood lymphocyte populations following surgery. J Clin Lab Immunol. 1986;20:75-9.
44.
Fletcher M, Azen S, and Adelsberg B. Immunophenotyping in a multicenter study: the Transfusion Safety Study experience. Clin Immunol Immunopathol. 1989;52:38-47.
Information & Authors
Information
Published In
Annals of Internal Medicine
Volume 113 • Number 10 • 15 November 1990
Pages: 733 - 739
History
Published in issue: 15 November 1990
Published online: 1 December 2008
Keywords
- Allergy and immunology
- Blood
- Blood banks
- Body fluids
- Cardiology and cardiovascular diseases
- Cardiovascular anatomy
- Cell biology
- Cells
- Clinical immunology
- Clinical trials
- Drug research and development
- Health care
- Health care facilities
- Heart
- HIV
- HIV infections
- Immunology
- Infectious diseases
- Lymphocytes
- Pathology and laboratory medicine
- Pharmacology
- Prevention, policy, and public health
- Pulmonary medicine
- Research and reporting methods
- Research facilities
- Respiratory system
- Retroviruses
- RNA viruses
- Viral diseases
- White blood cells
Copyright
© 1990 American College of Physicians.
Authors
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
Download article citation data for:
Infection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody-Positive Blood Donations. Ann Intern Med.1990;113:733-739. doi:10.7326/0003-4819-113-10-733
Infection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody-Positive Blood Donations. Ann Intern Med.1990;113:733-739. doi:10.7326/0003-4819-113-10-733
View More
Get Access
Login Options:
Purchase
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
Create your Free Account
You will be redirected to acponline.org to create an account that will provide access to Annals.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.